CRISPR Medicine (@crisprmedicine) 's Twitter Profile
CRISPR Medicine

@crisprmedicine

We write about CRISPR Medicine โ€“ the reagents, delivery methods, safety, quality control, clinical trials, standards and best practices...

ID: 1189826406676602880

linkhttps://crisprmedicinenews.com calendar_today31-10-2019 08:49:54

1,1K Tweet

2,2K Followers

276 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

๐Ÿ”ฅThe 9th Round of Easy Loan, Earn $40 Reward is in progressโ—๏ธ โฐ Promotion Period: January 15th - Feburary 15th, 2025 ๐Ÿ‘‰ Register now and check more details at gate.io/campaigns/358

๐Ÿ”ฅThe 9th Round of Easy Loan, Earn $40 Reward is in progressโ—๏ธ โฐ Promotion Period: January 15th - Feburary 15th, 2025 ๐Ÿ‘‰ Register now and check more details at gate.io/campaigns/358
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐๐ž๐š๐ฆ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐๐ซ๐จ๐จ๐Ÿ-๐Ž๐Ÿ-๐‚๐จ๐ง๐œ๐ž๐ฉ๐ญ ๐ƒ๐š๐ญ๐š ๐ข๐ง ๐€๐ฅ๐ฉ๐ก๐š-1 ๐€๐ง๐ญ๐ข๐ญ๐ซ๐ฒ๐ฉ๐ฌ๐ข๐ง ๐ƒ๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐“๐ซ๐ข๐š๐ฅ Beam Therapeutics has announced positive initial data from itsย Phase 1/2 clinical trial of BEAM-302

๐๐ž๐š๐ฆ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐๐ซ๐จ๐จ๐Ÿ-๐Ž๐Ÿ-๐‚๐จ๐ง๐œ๐ž๐ฉ๐ญ ๐ƒ๐š๐ญ๐š ๐ข๐ง ๐€๐ฅ๐ฉ๐ก๐š-1 ๐€๐ง๐ญ๐ข๐ญ๐ซ๐ฒ๐ฉ๐ฌ๐ข๐ง ๐ƒ๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐“๐ซ๐ข๐š๐ฅ Beam Therapeutics has announced positive initial data from itsย Phase 1/2 clinical trial of BEAM-302
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐Ÿงฌ ๐‚๐‘๐ˆ๐’๐๐‘๐Œ๐„๐ƒ25 ๐•๐ข๐ซ๐ญ๐ฎ๐š๐ฅ ๐„๐ฏ๐ž๐ง๐ญ - ๐‘๐ž๐ ๐ข๐ฌ๐ญ๐ž๐ซ ๐๐จ๐ฐ ๐Ÿงฌ Mark your calendar for April 7th, 2025! The CRISPR Medicine Conference 2025 brings together world-leading experts in gene-editing technology and applications. Meet our incredible lineup of speakers

๐Ÿงฌ ๐‚๐‘๐ˆ๐’๐๐‘๐Œ๐„๐ƒ25 ๐•๐ข๐ซ๐ญ๐ฎ๐š๐ฅ ๐„๐ฏ๐ž๐ง๐ญ - ๐‘๐ž๐ ๐ข๐ฌ๐ญ๐ž๐ซ ๐๐จ๐ฐ ๐Ÿงฌ Mark your calendar for April 7th, 2025! The CRISPR Medicine Conference 2025 brings together world-leading experts in gene-editing technology and applications. Meet our incredible lineup of speakers
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐†๐ž๐ง๐„-๐‡๐ฎ๐ฆ๐ƒ๐ข ๐–๐ž๐›๐ข๐ง๐š๐ซ ๐€๐ฅ๐ž๐ซ๐ญ: (๐„๐ฉ๐ข)๐ ๐ž๐ง๐จ๐ฆ๐ž ๐ž๐๐ข๐ญ๐ข๐ง๐  ๐ข๐ง ๐‚๐€๐‘ ๐“ ๐œ๐ž๐ฅ๐ฅ๐ฌ ๐Ÿ—“๏ธ Don't miss the next GeneHumdi webinar this coming Wednesday where Maria Silvia Roman Azcona at Universitรฉ de Fribourg - Universitรคt Freiburg will present her research

๐†๐ž๐ง๐„-๐‡๐ฎ๐ฆ๐ƒ๐ข ๐–๐ž๐›๐ข๐ง๐š๐ซ ๐€๐ฅ๐ž๐ซ๐ญ: (๐„๐ฉ๐ข)๐ ๐ž๐ง๐จ๐ฆ๐ž ๐ž๐๐ข๐ญ๐ข๐ง๐  ๐ข๐ง ๐‚๐€๐‘ ๐“ ๐œ๐ž๐ฅ๐ฅ๐ฌ ๐Ÿ—“๏ธ Don't miss the next GeneHumdi webinar this coming Wednesday where Maria Silvia Roman Azcona at Universitรฉ de Fribourg - Universitรคt Freiburg will present her research
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐˜๐จ๐ฎ๐ซ ๐‚๐‘๐ˆ๐’๐๐‘ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐–๐ž๐ž๐ค๐ฅ๐ฒ ๐ง๐ž๐ฐ๐ฌ ๐๐ซ๐จ๐ฉ ๐ข๐ฌ ๐ก๐ž๐ซ๐ž! ๐ŸŸข Scientists at Duke University โž and NC State University report new Cas9 orthologues with massive potential for human health applications. ๐Ÿ”ต A team Queen Mary University of London along with collaborators present a

๐˜๐จ๐ฎ๐ซ ๐‚๐‘๐ˆ๐’๐๐‘ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐–๐ž๐ž๐ค๐ฅ๐ฒ ๐ง๐ž๐ฐ๐ฌ ๐๐ซ๐จ๐ฉ ๐ข๐ฌ ๐ก๐ž๐ซ๐ž! ๐ŸŸข Scientists at <a href="/DukeUniversity9/">Duke University โž</a> and <a href="/NCState/">NC State University</a> report new Cas9 orthologues with massive potential for human health applications. ๐Ÿ”ต A team <a href="/QMUL/">Queen Mary University of London</a> along with collaborators present a
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐’๐ข๐ง๐ ๐ฅ๐ž-๐ƒ๐จ๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐†๐ž๐ง๐จ๐ฆ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐”๐ฌ๐ข๐ง๐  ๐‹๐ข๐ฉ๐ข๐ ๐๐š๐ง๐จ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž๐ฌ ๐’๐ก๐จ๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ๐ข๐ฌ๐ž ๐ข๐ง ๐Œ๐จ๐ฎ๐ฌ๐ž ๐Œ๐จ๐๐ž๐ฅ๐ฌ ๐จ๐Ÿ ๐‘๐š๐ซ๐ž ๐Œ๐ž๐ญ๐š๐›๐จ๐ฅ๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž Scientists used lipid nanoparticles to deliver

๐’๐ข๐ง๐ ๐ฅ๐ž-๐ƒ๐จ๐ฌ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐†๐ž๐ง๐จ๐ฆ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐”๐ฌ๐ข๐ง๐  ๐‹๐ข๐ฉ๐ข๐ ๐๐š๐ง๐จ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž๐ฌ ๐’๐ก๐จ๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ๐ข๐ฌ๐ž ๐ข๐ง ๐Œ๐จ๐ฎ๐ฌ๐ž ๐Œ๐จ๐๐ž๐ฅ๐ฌ ๐จ๐Ÿ ๐‘๐š๐ซ๐ž ๐Œ๐ž๐ญ๐š๐›๐จ๐ฅ๐ข๐œ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž Scientists used lipid nanoparticles to deliver
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐…๐ƒ๐€ ๐‚๐ฅ๐ž๐š๐ซ๐ฌ ๐…๐ข๐ซ๐ฌ๐ญ-๐„๐ฏ๐ž๐ซ ๐ˆ๐ง ๐•๐ข๐ฏ๐จ ๐†๐ž๐ง๐ž-๐„๐๐ข๐ญ๐ข๐ง๐  ๐“๐ซ๐ข๐š๐ฅ ๐Ÿ๐จ๐ซ ๐‚๐ก๐ซ๐จ๐ง๐ข๐œ ๐‡๐ž๐ฉ๐š๐ญ๐ข๐ญ๐ข๐ฌ ๐ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ Precision BioSciences, Inc. has received IND clearance from the FDA for PBGENE-HBV, making it the first

๐…๐ƒ๐€ ๐‚๐ฅ๐ž๐š๐ซ๐ฌ ๐…๐ข๐ซ๐ฌ๐ญ-๐„๐ฏ๐ž๐ซ ๐ˆ๐ง ๐•๐ข๐ฏ๐จ ๐†๐ž๐ง๐ž-๐„๐๐ข๐ญ๐ข๐ง๐  ๐“๐ซ๐ข๐š๐ฅ ๐Ÿ๐จ๐ซ ๐‚๐ก๐ซ๐จ๐ง๐ข๐œ ๐‡๐ž๐ฉ๐š๐ญ๐ข๐ญ๐ข๐ฌ ๐ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ Precision BioSciences, Inc. has received IND clearance from the FDA for PBGENE-HBV, making it the first
CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

We look forward to meeting Nature Biotechnology's Associate Editor Alexandra Despang at CRISPRMED25!!

CRISPR Medicine (@crisprmedicine) 's Twitter Profile Photo
CRISPR Medicine
@crisprmedicine

3 months ago

๐…๐ƒ๐€ ๐œ๐ฅ๐ž๐š๐ซ๐ฌ ๐Ÿ๐ข๐ซ๐ฌ๐ญ-๐ž๐ฏ๐ž๐ซ ๐ข๐ง ๐ฏ๐ข๐ฏ๐จ ๐ ๐ž๐ง๐ž-๐ž๐๐ข๐ญ๐ข๐ง๐  ๐ญ๐ซ๐ข๐š๐ฅ ๐Ÿ๐จ๐ซ ๐‡๐ž๐ฉ๐š๐ญ๐ข๐ญ๐ข๐ฌ ๐ ๐Ÿงฌ Precision BioSciences recently received FDA clearance for PBGENE-HBV, making it the first in vivo gene-editing candidate to enter a trial for chronic HBV in

๐…๐ƒ๐€ ๐œ๐ฅ๐ž๐š๐ซ๐ฌ ๐Ÿ๐ข๐ซ๐ฌ๐ญ-๐ž๐ฏ๐ž๐ซ ๐ข๐ง ๐ฏ๐ข๐ฏ๐จ ๐ ๐ž๐ง๐ž-๐ž๐๐ข๐ญ๐ข๐ง๐  ๐ญ๐ซ๐ข๐š๐ฅ ๐Ÿ๐จ๐ซ ๐‡๐ž๐ฉ๐š๐ญ๐ข๐ญ๐ข๐ฌ ๐ ๐Ÿงฌ Precision BioSciences recently received FDA clearance for PBGENE-HBV, making it the first in vivo gene-editing candidate to enter a trial for chronic HBV in
Integra Therapeutics (@integra_tx) 's Twitter Profile Photo
Integra Therapeutics
@integra_tx

3 months ago

Join Integra Therapeutics at #CRISPRMED25 to hear from our Head of Cell Engineering, Paolo Petazzi, and CEO, Avencia Sanchez-Mejias PhD, as they share the latest preclinical data on our groundbreaking #FiCAT platform. ๐Ÿ“ Copenhagen (April 8-11) ๐Ÿ’ป Virtual (April 7) event.fourwaves.com/crisprmed25/paโ€ฆ

Join Integra Therapeutics at #CRISPRMED25 to hear from our Head of Cell Engineering, Paolo Petazzi, and CEO, <a href="/avenciasm/">Avencia Sanchez-Mejias PhD</a>, as they share the latest preclinical data on our groundbreaking #FiCAT platform. ๐Ÿ“ Copenhagen (April 8-11) ๐Ÿ’ป Virtual (April 7) event.fourwaves.com/crisprmed25/paโ€ฆ
Scribe Therapeutics (@scribetx) 's Twitter Profile Photo
Scribe Therapeutics
@scribetx

2 months ago

Tune in Monday, April 7 at 3:25 p.m. CEST (6:25 a.m. PT) to learn how Scribe is revolutionizing the treatment paradigm for cardiometabolic disease and our latest advances in developing in vivo #CRISPR-based medicines for dyslipidemia. event.fourwaves.com/crisprmed25/scโ€ฆ CRISPR Medicine

Nature Biotechnology (@naturebiotech) 's Twitter Profile Photo
Nature Biotechnology
@naturebiotech

2 months ago

ETH Zurich CRISPR enhancer increases precision โ€” and destroys DNA #NBTintheNews via CRISPR Medicine crisprmedicinenews.com/news/crispr-enโ€ฆ

Miccio lab (@labmiccio) 's Twitter Profile Photo
Miccio lab
@labmiccio

2 months ago

CRISPR Medicine Great congress, thanks CRISPR Medicine News for giving us the possibility to discuss novel editing approaches, patient accessibility, and much more!

<a href="/CrisprMedicine/">CRISPR Medicine</a> Great congress, thanks CRISPR Medicine News for giving us the possibility to discuss novel editing approaches, patient accessibility, and much more!
GENYO (@genyo_pts) 's Twitter Profile Photo
GENYO
@genyo_pts

2 months ago

Karim Benabdellah was a member of the scientific committee and chairperson at the 2nd Conference on CRISPR Medicine , held in Copenhagen from 8 to 11 April 2025 Cost Action GenE-Humdi #CRISPRMedicine2025 #CancerImmunotherapy #GeneEditing #CAR-T

Karim Benabdellah was a member of the scientific committee and chairperson at the 2nd Conference on <a href="/CrisprMedicine/">CRISPR Medicine</a> , held in Copenhagen from 8 to 11 April 2025 <a href="/GeneHumdi/">Cost Action GenE-Humdi</a> #CRISPRMedicine2025 #CancerImmunotherapy #GeneEditing #CAR-T
Rollup News (@rollup_news) 's Twitter Profile Photo
Rollup News
@rollup_news

2 months ago

Mehrab Hossain Nature Biotechnology CRISPR Medicine Dive into the future of medicine at the CRISPR Medicine Conference! rollup.news/r/N-M

Institut de Recerca Sant Joan de Dรฉu (@irsjd_info) 's Twitter Profile Photo
Institut de Recerca Sant Joan de Dรฉu
@irsjd_info

2 months ago

๐Ÿ”ฌโœจ La Dra. Cecilia Jimรฉnez-Mallebrera i el Dr. Arรญstides Lรณpez-Mรกrquez investigadors de lโ€™@IRSJD_org han presentat els seus avenรงos cientรญfics en ediciรณ gรจnica per a distrรฒfies musculars congรจnites al congrรฉs CRISPR Medicine de Copenhaguen. #RecercaIRSJD #CRISPR #MalaltiesRares

๐Ÿ”ฌโœจ La Dra. Cecilia Jimรฉnez-Mallebrera i el Dr. Arรญstides Lรณpez-Mรกrquez investigadors de lโ€™@IRSJD_org han presentat els seus avenรงos cientรญfics en ediciรณ gรจnica per a distrรฒfies musculars congรจnites al congrรฉs <a href="/CrisprMedicine/">CRISPR Medicine</a> de Copenhaguen. #RecercaIRSJD #CRISPR #MalaltiesRares
Institut de Recerca Sant Joan de Dรฉu (@irsjd_info) 's Twitter Profile Photo
Institut de Recerca Sant Joan de Dรฉu
@irsjd_info

2 months ago

CRISPR Medicine ๐Ÿ”ฌโœจ La Dra. Cecilia Jimรฉnez-Mallebrera y el Dr. Arรญstides Lรณpez-Mรกrquez investigadors de @IRSJD_org han presentado sus avances cientรญficos en ediciรณn gรฉnica para distrofias musculares congรฉnitas en el congreso CRISPR Medicine. #InvestigaciรณnIRSJD #CRISPR #EnfermedadesRaras

<a href="/CrisprMedicine/">CRISPR Medicine</a> ๐Ÿ”ฌโœจ La Dra. Cecilia Jimรฉnez-Mallebrera y el Dr. Arรญstides Lรณpez-Mรกrquez investigadors de @IRSJD_org han presentado sus avances cientรญficos en ediciรณn gรฉnica para distrofias musculares congรฉnitas en el congreso <a href="/CrisprMedicine/">CRISPR Medicine</a>. #InvestigaciรณnIRSJD #CRISPR #EnfermedadesRaras
Institut de Recerca Sant Joan de Dรฉu (@irsjd_info) 's Twitter Profile Photo
Institut de Recerca Sant Joan de Dรฉu
@irsjd_info

2 months ago

CRISPR Medicine ๐Ÿ”ฌโœจ Dr. Cecilia Jimรฉnez-Mallebrera and Dr. Arรญstides Lรณpez-Mรกrquez from @IRSJD_org presented their latest scientific advances in gene editing for congenital muscular dystrophies at the CRISPR Medicine conference in Copenhagen. #IRSJDResearch #CRISPR #RareDiseases

<a href="/CrisprMedicine/">CRISPR Medicine</a> ๐Ÿ”ฌโœจ Dr. Cecilia Jimรฉnez-Mallebrera and Dr. Arรญstides Lรณpez-Mรกrquez from @IRSJD_org presented their latest scientific advances in gene editing for congenital muscular dystrophies at the <a href="/CrisprMedicine/">CRISPR Medicine</a> conference in Copenhagen. #IRSJDResearch #CRISPR #RareDiseases
Emil Lou, MD, PhD, FACP (@cancerassassin1) 's Twitter Profile Photo
Emil Lou, MD, PhD, FACP
@cancerassassin1

2 months ago

Results from the clinical trial targeting the intracellular immune checkpoint CISH in patients with GI cancers will be presented next Tuesday April 29 at #AACR25: abstractsonline.com/pp8/#!/20273/pโ€ฆ

Results from the clinical trial targeting the intracellular immune checkpoint CISH in patients with GI cancers will be presented next Tuesday April 29 at #AACR25: abstractsonline.com/pp8/#!/20273/pโ€ฆ